ARGENX SE is 7.3x more valuable than ImmunityBio, Inc. by market capitalization ($53.35 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IBRX | ARGX |
|---|---|---|
| Market cap | $7.31 B | $53.35 B |
| US-listed rank | #1121 | #306 |
| Revenue (latest FY) | $113.29M | - |
| Net income (latest FY) | -$351.50M | - |
| Net margin | -310.3% | - |
| SEC filings | 528 | 272 |
ARGENX SE is 7.3x more valuable than ImmunityBio, Inc. by market capitalization ($53.35 B vs $7.31 B).
Full pages: ImmunityBio, Inc. and ARGENX SE, or browse the full rankings.